Innocan Pharma Corporation: Innocan Pharma Announces the Ina

Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - January 17, 2022) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan") is pleased to announce that it

Related Keywords

Jerusalem , Israel General , Israel , Herzliya , Tel Aviv , Canada , Hebrew University , Yerushalayim , Canadian , Iris Bincovich , Chezy Barenholz , Innocan Pharma , Company Or Innocan , Innocan Pharma Corporation , Platform Technology , Liposome Research Department , Lytham Partners , Biohouse Labs At Hadassah Medical Center , Hebrew University Of Jerusalem , Alberta Newsfile Corp , Tel Aviv University , Pharma Corporation , Biohouse Labs , Hadassah Medical Center , License Agreement , Professor Chezy Barenholz , Professor Barenholz , Innocan Israel , Vice President , Innocan , Dharma , Corporation , Nnounces , Inauguration , Drug , Development , Iohouse , Hadassah , Medical , Center ,